Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo has shown efficacy in immunocompromised adults, the pharma announced Monday. In substudy B of Pfizer’s ongoing Phase 3 MONeT trial, Abrysvo ...
Pfizer has officially thrown its hat in the weight-loss ring. The company’s GLP-1 receptor agonist, danuglipron, showed promise in an ongoing pharmacokinetic study, it announced Thursday. Pfizer plans ...
Pfizer Inc forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit ...
Pfizer has added another chapter to its long-running drug discovery collaboration with Chinese tech startup XtalPi, this time upgrading their molecular modeling work. The aim is to help “grasp ...
Pfizer and BioNTech announced Thursday that they have begun a study to test a combination vaccine for COVID-19 and the flu. In a news release, the drugmakers said they started a Phase 1 trial of an ...
Cipla Ltd has inked an exclusive agreement with Pfizer India to market, distribute, and sell the latter's four brands across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback